Government proposes defibrillator-style naloxone access The emergency opioid treatment could also be made available without a prescription at hostels and homeless outreach services, government proposals say.…
Health news round-up: orforglipron, new gonorrhoea antibiotics and record high flu admissions A weekly summary of important developments in health news that you may have missed.…
Regulator consults on pharmacist standards following new legislation The General Pharmaceutical Council’s consultation sets out what the accountabilities and responsibilities of pharmacists and pharmacy technicians would be if they were authorised to carry out certain tasks.…
Pills, policy and prescribing: 2025 in numbers From medicines spending to the ten-year health plan, 2025 has been a noteworthy year for statistics. We present our top picks and headline numbers from our coverage across pharmacy this year.…
NICE medicines thresholds: what’s changing and where is the money coming from? An insight into medicines spending and what changes can be expected from new National Institute for Health and Care Excellence cost-effectiveness thresholds.…
Health news round-up: haematology, mental health and pharmacogenomics A weekly summary of important developments in health news that you may have missed.…
Health news round-up: the year in health across England, Scotland and Wales A weekly summary of important developments in health news, with summaries from each of the Welsh, Scottish and English chief medical officers’ annual reports.…
Whooping cough nasal vaccine shows promise in phase II trial Researchers reported that participants who were given BPZE1 and then exposed to the whooping cough bacteria were unlikely to pass the infection on to others after day 14 post-challenge.…
Collaboration to diversify trial participation through community pharmacies launched The National Pharmacy Association and the Centre for Research Equity have outlined plans to develop a network of research sites in community pharmacies to support inclusive participation in research.…
NICE cost-effectiveness thresholds increased as UK strikes trade deal with United States The adjusted threshold could allow the approval of an additional three to five medicines for use on the NHS in England each year.…
